Material Agreements

Canopy Growth Corp entered into Second Amended and Restated Limited Liability Company Agreement with Canopy USA, LLC and its members, 11065520 Canada Inc. and the Huneeus 2017 Irrevocable Trust (effective 2024-04-30).

“On April 30, 2024, Canopy USA and its members, 11065520 Canada Inc. and the Huneeus 2017 Irrevocable Trust, entered into a Second Amended and Restated Limited Liability Company Agreement (the “ Second A&R LLC Agreement ”) which amended and restated the prior amended and restated limited liability company agreement of Canopy USA”

Gossamer Bio, Inc. entered into Chiesi Collaboration Agreement with Chiesi Farmaceutici S.p.A and Chiesi USA, Inc. (collectively, Chiesi) valued at Upfront payment of $160 million, plus up to $146 million in regulatory milestones and $180 million i (effective 2024-05-03).

“On May 3, 2024, Gossamer Bio, Inc. (“Gossamer” or the “Company”), GB002, Inc., a Delaware corporation and wholly-owned subsidiary of the Company (“GB002”), and Gossamer Bio 002 Ltd., a corporation organized and existing under the laws of Ireland and indirect wholly-owned subsidiary of the Company, entered into a global collaboration and license agreement (the “Chiesi Collaboration Agreement”) with Chiesi Farmaceutici S.p.A and Chiesi USA, Inc. (collectively, “Chiesi”). The collaboration is focused on the development and commercialization of seralutinib and licensed products including seralutinib and related licensed compounds (“Licensed Products”) in the US (“US Territory”) and the rest of the world (“ROW Territory”), for therapeutic, prophylactic and diagnostic uses in humans and animals, for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD) and other indications, as may be permitted under the Chiesi Co”

HF Foods Group Inc. entered into Assignment and Assumption of Lease Agreement with 273 Fifth Avenue, L.L.C. (effective 2024-04-30).

“On April 30, 2024, 273 Fifth Avenue, L.L.C. (“Assignee”), a Delaware limited liability company and wholly owned subsidiary of the Company assumed the lease of the premises at 275 Fifth Avenue, New York, New York, dated as of July 2, 2018 (the "Lease"), as amended by that certain Amendment to Lease, dated as of January 21, 2021, (the “Amendment to Lease”), between 825 Broadway Realty, LLC, Samayabeneli RE LLC, AS 2 East 30, LLC, 273 Yoco LLC, and UBA 2 East 30, LLC (collectively, the “Landlord”), and Anheart Inc., a New York corporation and a former subsidiary of the Company (the “Assignor”), pursuant to an Assignment and Assumption of Lease Agreement (the “Assignment”), dated as of August 16, 2022 and effective between Assignor and Assignee as of April 30, 2024 (the “Effective Date”), when Landlord consent was obtained.”

Corvus Pharmaceuticals, Inc. entered into Securities Purchase Agreement with the investors named therein, including the companys chief executive officer and certain of the companys existing institutional investors, including investors affiliated with certain of the companys directors (collectively, the Investors ) valued at combined offering price of $1.7312 (effective 2024-05-01).

“On May 1, 2024, Corvus Pharmaceuticals, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with the investors named therein, including the Company’s chief executive officer and certain of the Company’s existing institutional investors, including investors affiliated with certain of the Company’s directors (collectively, the “Investors”).”

Braemar Hotels & Resorts Inc. entered into Agreement of Purchase and Sale with JRK Torrey Pines Hotel Owner LLC valued at $165 million (effective 2024-05-06).

“On May 6, 2024 (the “Effective Date”), CHH Torrey Pines Hotel Partners, LP and CHH Torrey Pines Tenant Corp. (together, “Seller”), indirect subsidiaries of Braemar Hotels & Resorts Inc. (the “Company”), entered into an Agreement of Purchase and Sale (the “Agreement”) with JRK Torrey Pines Hotel Owner LLC (“Purchaser”), for the sale of the Hilton La Jolla Torrey Pines hotel (“Hilton Torrey Pines”) for $165 million in cash”

Arch Therapeutics, Inc. amended Amendment No. 2 to the Fourth Notes with holders of the Company's outstanding Unsecured Convertible Promissory Notes valued at Under the Amendments to the Notes, the Notes were amended to extend the date of the completion of an (effective 2024-04-30).

“On April 30, 2024, the Company also entered into an amendment (" Amendment No. 2 to the Fourth Notes " and, together with Amendment No. 16 to the First Notes, Amendment No. 16 to the Second Notes and Amendment No. 11 to the Third Notes, the " Amendments to the Notes ") with the holders of the Company's outstanding Unsecured Convertible Promissory Notes, as separately amended on March 15, 2024, issued in connection with a private placement financing the Company completed on March 12, 2024 (as amended, the " Fourth Notes " and, together with the First Notes, Second Notes, and Third Notes, the " Notes ").”

Arch Therapeutics, Inc. amended Amendment No. 11 to the Third Notes with holders of the Company's outstanding Unsecured Convertible Promissory Notes valued at Under the Amendments to the Notes, the Notes were amended to extend the date of the completion of an (effective 2024-04-30).

“On April 30, 2024, the Company also entered into an amendment (" Amendment No. 11 to the Third Notes ") with the holders of the Company's outstanding Unsecured Convertible Promissory Notes, as separately amended on June 15, 2023, July 1, 2023, July 7, 2023, July 31, 2023, August 30, 2023, September 30, 2023, October 31, 2023, November 15, 2023, January 5, 2024 and March 15, 2024 (as amended, the " Third Notes "), issued in connection with a private placement financing the Company completed on May 15, 2023.”

Arch Therapeutics, Inc. amended Amendment No. 16 to the Second Notes with holders of the Company's outstanding Unsecured Convertible Promissory Notes valued at Under the Amendments to the Notes, the Notes were amended to extend the date of the completion of an (effective 2024-04-30).

“On April 30, 2024, the Company also entered into an amendment (" Amendment No. 16 to the Second Notes ") with the holders of the Company's outstanding Unsecured Convertible Promissory Notes, as separately amended on February 14, 2023, March 10, 2023, March 15, 2023, April 15, 2023, May 15, 2023, June 15, 2023, July 1, 2023, July 7, 2023, July 31, 2023, August 30, 2023, September 30, 2023, October 31, 2023, November 15, 2023, January 5, 2024 and March 15, 2024 (as amended, the " Second Notes "), issued in connection with a private placement financing the Company completed on January 18, 2023.”

Arch Therapeutics, Inc. amended Amendment No. 4 to the Bridge Registration Rights Agreement with certain institutional and accredited individual investors valued at Amended to redefine 'Uplist' as the public offering of the Company's Common Stock pursuant to a regi (effective 2024-05-01).

“On May 1, 2024, the Company entered into an amendment (" Amendment No. 4 to the Bridge Registration Rights Agreement ") to that certain Registration Rights Agreement, dated as of July 7, 2023, as amended on August 30, 2023, and as subsequently amended on November 8, 2023 and November 21, 2023, by and among the Company and certain institutional and accredited individual investors (as amended the " Bridge Registration Rights Agreement ") in connection with a private placement offering of pre-funded warrants to purchase shares of Common Stock, common warrants to purchase shares of Common Stock, and shares of Common Stock. Under Amendment No. 4 to the Bridge Registration Rights Agreement, the Bridge Registration Rights Agreement was amended to redefine "Uplist" as the public offering of the Company's Common Stock pursuant to a registration statement on Form S-1 that results in the listing of the Company's Common Stock on any securities exchange registered with the SEC as a "national securi”

Arch Therapeutics, Inc. amended Amendment No. 1 to the Third A&R Registration Rights Agreement with certain institutional and accredited individual investors valued at Amended to redefine 'Uplist Transaction' as the listing of the Company's common stock on any securit (effective 2024-04-30).

“On April 30, 2024, Arch Therapeutics, Inc. (the " Company ") entered into an amendment (" Amendment No. 1 to the Third A&R Registration Rights Agreement ") to that certain Third Amended and Restated Registration Rights Agreement, dated as of March 12, 2024, by and among us and certain institutional and accredited individual investors, as amended (the " A&R Registration Rights Agreement "). Under Amendment No. 1 to the Third A&R Registration Rights Agreement, the A&R Registration Rights Agreement was amended to redefine "Uplist Transaction" as the listing of the Company's common stock, par value $0.001 (" Common Stock "), on any securities exchange registered with the U.S. Securities and Exchange Commission (" SEC ") as a "national securities exchange" under Section 6 of the Securities Exchange Act of 1934, as amended (the " Exchange Act ").”

Premier Air Charter Holdings Inc. amended Amendment No. 2 to the Agreement and Plan of Merger with TIPP Aviation, LLC (effective 2024-05-01).

“On May 1, 2024, the registrant ("Altair") executed Amendment No. 2 to the Agreement and Plan of Merger (“Amendment 2 to Merger Agreement”) among Premier Air Charter, Inc. (“Premier”), Premier Air Charter Merger Sub, Inc. (“Merger Sub”), and TIPP Aviation, LLC, the sole shareholder of Premier.”

Contango Silver & Gold Inc. entered into Arrangement Agreement with HighGold Mining Inc. valued at total HighGold equity value of approximately $37 million (effective 2024-05-01).

“On May 1, 2024, Contango ORE, Inc. (“Contango” or the “Company”) entered into a definitive arrangement agreement (the “Arrangement Agreement”), by and among the Company, Contango Mining Canada Inc., a corporation organized under the laws of British Columbia and a wholly owned subsidiary of the Company, and HighGold Mining Inc., a corporation existing under the laws of the Province of British Columbia (“HighGold”), pursuant to which the Company intends to acquire 100% of the outstanding equity interests of HighGold (the “HighGold Acquisition”).”

T2 Biosystems, Inc. entered into Consent and Amendment No. 11 to Term Loan Agreement with Administrative Agent and Lenders under the Loan Agreement (effective 2024-05-03).

“On May 3, 2024, the Company entered into the Consent and Amendment No. 11 to Term Loan Agreement (“ Consent No. 11 ”) to the Loan Agreement. Consent No. 11 provides for, among other things, (i) the consent of the Administrative Agent and the Lenders (who constitute all of the lenders under the Loan Agreement) to the Exchange and (ii) an amendment to the “Change of Control” definition”

T2 Biosystems, Inc. entered into Securities Purchase Agreement with CRG Partners III L.P., CRG Partners III - Parallel Fund "A" L.P., CRG Partners III (Cayman) Unlev AIV I L.P., CRG Partners III (Cayman) Lev AIV I L.P. and CRG Partners III Parallel Fund "B" (Cayman) L.P. valued at $15.0 million (effective 2024-05-03).

“On May 3, 2024, the Company entered into a Securities Purchase Agreement (the “ SPA ”) with CRG Partners III L.P., CRG Partners III - Parallel Fund “A” L.P., CRG Partners III (Cayman) Unlev AIV I L.P., CRG Partners III (Cayman) Lev AIV I L.P. and CRG Partners III Parallel Fund “B” (Cayman) L.P. (collectively in such capacity, the “ Lenders ” or the “ Purchasers ”) pursuant to which the Company issued to the Lenders in a private placement offering 4,748,335 shares (the “ Shares ”) of the Company’s common stock in exchange for the Lenders surrendering for cancellation $15.0 million of outstanding loans”

Sweetgreen, Inc. amended Letter Agreement with Welcome to the Dairy, LLC valued at Landlord receives 100% of Company's profits under Sublease in excess of amounts payable under Lease; (effective 2024-04-30).

“In connection with the Landlord’s consent to the Sublease Agreement, the Company and the Landlord entered into a letter agreement, dated as of April 30, 2024, modifying the terms of the Lease (the “ Letter Agreement ”).”

Sweetgreen, Inc. entered into Sublease Agreement with FPM Development, LLC valued at Monthly base rent ranging from $399,844.25 to $491,757.99; annual base rent from $4,398,286.75 to $5 (effective 2024-04-30).

“On April 30, 2024, Sweetgreen, Inc. (the “ Company ”) entered into a sublease agreement (the “ Sublease Agreement ”) with FPM Development, LLC, a Wyoming limited liability company (the “ Subtenant ”), pursuant to which the Company will sublease approximately 57,681 square feet of space (the “ Phase I Premises ”) and approximately 36,400 square feet of space (the “ Phase II Premises ” and together with the Phase I Premises, the “ Premises ”) located at 3101 Exposition Boulevard, Los Angeles, California 90018.”

Axe Compute Inc. entered into Sales Agreement with H.C. Wainwright & Co., LLC valued at $3,696,000 (effective 2024-05-03).

“On May 3, 2024, Predictive Oncology Inc., a Delaware corporation, (the “Company”), entered into an ATM Sales Agreement (the “Sales Agreement”) with H.C. Wainwright & Co., LLC (“Wainwright”), as sales agent to sell shares of the Company’s common stock, par value $0.01 per share, from time to time, through an “at the market offering” program pursuant to which Wainwright will act as sales agent.”

Appgate, Inc. amended A&R Note Issuance Agreement with Magnetar Financial LLC (effective 2024-05-02).

“(“ ES Colombia ” and, collectively with the Domestic Subsidiary Guarantors, Appgate and ES Japan, the “ Note Guarantors ”), Magnetar Financial LLC (collectively with its affiliates, “ Magnetar ”), as representative of the lenders, (the “ Lenders ”) party to that certain A&R Note Purchase Agreement, dated June 9, 2023, by and among Legacy Appgate and the Lenders (the “ A&R Note Purchase Agreement ”), and U.S.”

Cardinal Ethanol LLC amended First Amendment of Second Amended and Restated Construction Loan Agreement with First National Bank of Omaha (effective 2024-04-30).

“On April 30, 2024, Cardinal Ethanol, LLC, and its wholly owned subsidiary, Cardinal Colwich, LLC (collectively the “Company”), executed a First Amendment of Second Amended and Restated Construction Loan Agreement, which amends the Second Amended and Restated Construction Loan Agreement dated January 31, 2024, with First National Bank of Omaha (the "Amendment").”

Zoned Properties, Inc. amended First Amendment to the Absolute Net Lease Agreement with Rapid Fish, LLC (effective 2024-05-01).

“On May 1, 2024, ZP Woodward and Rapid Fish, LLC (the “Parties”), with individual Guarantors, Thomas Nafso and Ammar Kattoula (the “Guarantors”), entered into a First Amendment to the Absolute Net Lease Agreement (the “First Amendment”) pertaining to premises located at 23600-23634 Woodward Ave, Pleasant Ridge MI 48069.”

COGENT COMMUNICATIONS HOLDINGS, INC. entered into New Guarantor Supplemental Indentures with Sprint Solutions Wireline LLC (effective 2024-05-02).

“On the Closing Date, Cogent Group entered into a first supplemental indenture to each of the indentures governing the Existing Notes to add Sprint Solutions Wireline LLC as a guarantor of the Existing Notes (collectively, the "New Guarantor Supplemental Indentures")”

COGENT COMMUNICATIONS HOLDINGS, INC. entered into Guaranty with Cogent IPv4 Holdco LLC (effective 2024-05-02).

“The Notes are guaranteed by Cogent IPv4 Holdco LLC, a special-purpose entity and an indirect wholly owned subsidiary of the Company, as the Guarantor (the "Guarantor"), pursuant to a guaranty, dated as of the Closing Date (the "Guaranty")”

COGENT COMMUNICATIONS HOLDINGS, INC. entered into Series 2024-1 Supplement with Wilmington Trust, National Association valued at $206,000,000 aggregate principal amount of 7.924% secured IPv4 address revenue notes, Series 2024-1 (effective 2024-05-02).

“The Notes were issued pursuant to an indenture, dated as of the Closing Date (the "Base Indenture"), as supplemented by the Series 2024-1 Supplement thereto, dated as of the Closing Date (the "Series 2024-1 Supplement")”

COGENT COMMUNICATIONS HOLDINGS, INC. entered into Base Indenture with Wilmington Trust, National Association valued at $206,000,000 aggregate principal amount of 7.924% secured IPv4 address revenue notes, Series 2024-1 (effective 2024-05-02).

“The Notes were issued pursuant to an indenture, dated as of the Closing Date (the "Base Indenture"), as supplemented by the Series 2024-1 Supplement thereto, dated as of the Closing Date”

Applied Digital Corp. entered into Sales Agreement with Roth Capital Partners, LLC valued at $25,000,000 (effective 2024-05-06).

“On May 6, 2024, Applied Digital Corporation (the “Company”) entered into a Sales Agreement (the “Sales Agreement”) with Roth Capital Partners, LLC (the “Agent”), pursuant to which the Company may offer and sell, from time to time, through the Agent, up to $25,000,000 of shares of its common stock, par value $0.001 per share (the “Common Stock”).”

DZS INC. entered into Share Purchase Agreement with Casa Communications Holdings Pty Ltd (Administrators Appointed) valued at USD $7,000,000 (effective 2024-05-03).

“On May 3, 2024, DZS Inc., a Delaware corporation (the “ Company ”), entered into a Share Purchase Agreement (the “ Share Purchase Agreement ”) with Casa Communications Holdings Pty Ltd (Administrators Appointed) ACN 632 732 659, a private limited company registered in New South Wales, Australia (the “ Seller ”).”

TXNM ENERGY INC entered into Distribution Agreement with BofA Securities, Inc., Citigroup Global Markets Inc., MUFG Securities Americas Inc., RBC Capital Markets, LLC, Scotia Capital (USA) Inc. and Wells Fargo Securities, LLC, as Sales Agents; and Bank of America, N.A., Citibank, N.A., MUFG Securities EMEA plc, Royal Bank of Canada, The Bank of Nova Scoti valued at up to an aggregate sales price of $100 million (effective 2024-05-06).

“On May 6, 2024, PNM Resources, Inc. (the “Company”) entered into a Distribution Agreement (the “Distribution Agreement”) with BofA Securities, Inc., Citigroup Global Markets Inc., MUFG Securities Americas Inc., RBC Capital Markets, LLC, Scotia Capital (USA) Inc. and Wells Fargo Securities, LLC (each, a “Sales Agent” and collectively, the “Sales Agents”) and Bank of America, N.A., Citibank, N.A., MUFG Securities EMEA plc, Royal Bank of Canada, The Bank of Nova Scotia and Wells Fargo Bank, N.A., as Forward Purchasers (each, a “Forward Purchaser” and collectively, the “Forward Purchasers”), pursuant to which the Company may sell, from time to time, up to an aggregate sales price of $100 million of its common stock”

PERFICIENT INC entered into Agreement and Plan of Merger with Plano HoldCo, Inc. and Plano BidCo, Inc. valued at $76.00 (effective 2024-05-05).

“On May 5, 2024, Perficient, Inc., a Delaware corporation (the “ Company ” or “ Perficient ”), entered into an Agreement and Plan of Merger (the “ Merger Agreement ”) with Plano HoldCo, Inc., a Delaware corporation (“ Parent ”), and Plano BidCo, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“ Merger Sub ”).”

Precipio, Inc. entered into Business Loan and Security Agreement with Altbanq Lending LLC. valued at $250,000 (effective 2024-05-01).

“On May 1, 2024, Precipio, Inc. (the “Company”) entered into a Business Loan and Security Agreement (the “Loan Agreement”), by and between the Company, as borrower, and Altbanq Lending LLC., as lender (the “Lender”) pursuant to which the Company obtained a loan from the Lender in the principal amount of $250,000”

WILLIS LEASE FINANCE CORP entered into Credit Agreement with a syndicate of banks including Bank of America, N.A. and BNP Paribas valued at $500 million (effective 2024-05-03).

“On May 3, 2024, Willis Warehouse Facility LLC (the “Borrower”), a wholly owned subsidiary of Willis Lease Finance Corporation (“WLFC” or the “Company”), entered into a Secured Credit Agreement by and among the Borrower, the lenders party thereto, Bank of Utah, not in its individual capacity but solely as Security Trustee and Administrative Agent, and Bank of America, N.A., as Facility Agent, dated as of May 3, 2024 (the “Credit Agreement”).”

Ainos, Inc. entered into Convertible Note and Warrant Purchase Agreement with ASE Test, Inc. valued at US$9,000,000 (effective 2024-05-03).

“On May 3, 2024, Ainos, Inc., a Texas corporation (“Ainos”, “we” or the “Company”), entered into a Convertible Note and Warrant Purchase Agreement (the “Agreement”) with ASE Test, Inc., Taiwanese company (“ASE Test”), pursuant to which the Company issued to ASE Test a convertible note in the aggregate principal amount of US$9,000,000.”

RCI HOSPITALITY HOLDINGS, INC. entered into Loan Agreement with Centennial Bank valued at $20.0 million (effective 2024-04-30).

“On April 30, 2024, our wholly-owned subsidiary RCI Holdings, Inc. (“RCI Holdings”) entered into and closed a term loan with Centennial Bank for $20.0 million (the “Loan”).”

STARZ ENTERTAINMENT CORP /CN/ entered into Exchange Agreement with certain holders of 5.500% Senior Notes due 2029 valued at approximately $383 million (effective 2024-05-02).

“On May 2, 2024, Lions Gate Entertainment Corp. (the “ Company ”) entered into an Exchange Agreement (together with all annexes and schedules thereto, the “ Exchange Agreement ”) with Lions Gate Capital Holdings 1, Inc. (“ LGCH1 ”), Lions Gate Capital Holdings LLC (“ LGCH ”, and together with the Company and LGCH1, the “ Company Parties ”) and certain holders of 5.500% Senior Notes due 2029 (the “ Existing Notes ”) previously issued by LGCH (such holders, the “ Noteholder Parties ”, and together with the Company Parties, the “ Parties ”) pursuant to which the Parties agreed to enter into a private exchange of the Noteholder Parties’ Existing Notes for new 5.500% Exchange Notes due 2029 (the “ New Notes ”) to be issued by LGCH1.”

EAGLE MATERIALS INC entered into Put Option Agreement with HM Southeast Cement LLC and Heidelberg Materials US, Inc. valued at $1,100,000,000.00 (effective 2024-05-01).

“On May 1, 2024, the Company and the TLCC Partners, on the one hand, and HM and HMSC, on the other hand, entered into a Put Option Agreement (the “ Put Option Agreement ”) that provides for the grant of reciprocal put options by the parties with respect to their 50% partnership interests in the Joint Venture.”

Steel Connect, Inc. amended Second Amendment to Credit Agreement with Umpqua Bank (effective 2024-05-01).

“On May 1, 2024, ModusLink Corporation (“ ModusLink ”), a wholly-owned subsidiary of Steel Connect, Inc., entered into a Second Amendment to Credit Agreement (the “ Second Amendment ”), amending the Credit Agreement, dated as of March 16, 2022, as amended by that certain First Amendment to Credit Agreement, dated March 13, 2023, by and between ModusLink, as borrower, and Umpqua Bank, as lender and as agent (as amended from time to time, the “ Umpqua Facility ”).”

Enveric Biosciences, Inc. entered into Purchase Agreements with certain institutional investors valued at at a deemed offering price of $0.94 per share (effective 2024-05-03).

“On May 3, 2024, Enveric Biosciences, Inc., a Delaware corporation (the “Company”) entered into a series of common stock purchase agreements (the “Purchase Agreements”) for the issuance in a registered direct offering of an aggregate of 458,000 shares of the Company’s common stock, par value $0.01 per share (the “Shares”), to certain institutional investors.”

HST Global, Inc. entered into Reorganization and Stock Purchase Agreement with HP Auto Fund LLP ("HPAF"), HST Global Holdings, LLC ("HGHI"), Ron Howell ("Howell") and The Health Network, Inc. ("Health Network") (effective 2024-04-24).

“On April 24, 2024, HST Global, Inc., a Nevada Corporation (“HSTC”) entered into a Reorganization and Stock Purchase Agreement (the “Reorganization Agreement”) by and among HP Auto Fund LLP (“HPAF”), HST Global Holdings, LLC (“HGHI”), HST Global, Inc. (“HSTC”), Ron Howell (“Howell”) and The Health Network, Inc. (“Health Network”).”

LSB INDUSTRIES, INC. amended First Amendment with Computershare Trust Company, N.A. (effective 2024-05-02).

“On May 2, 2024, LSB Industries, Inc. (the “Company”) entered into the First Amendment (the “Amendment”) to the Amended and Restated Section 382 Rights Agreement (the “Amended and Restated Agreement”) dated August 22, 2023, between the Company and Computershare Trust Company, N.A., as rights agent.”

KELLY SERVICES INC entered into Agreement and Plan of Merger with MRP Merger Sub, Inc., MRP Topco Inc., Motion Recruitment Partners, LLC, and Littlejohn Fund V, L.P. valued at $425 million (effective 2024-05-02).

“On May 2, 2024, Kelly Services, Inc. (“Kelly”), MRP Merger Sub, Inc. (“Merger Sub”), a newly-formed, wholly-owned subsidiary of Kelly, MRP Topco Inc. (“Topco”), the indirect parent company of Motion Recruitment Partners, LLC (“Motion”), and Littlejohn Fund V, L.P. (“Littlejohn”), in its capacity as the securityholders’ representative, entered into an Agreement and Plan of Merger (the “Merger Agreement”) whereby Kelly would indirectly acquire 100% of the equity interests in Motion by way of a merger of Merger Sub with and into Topco, with Topco surviving the merger (the “Merger”).”

ABEONA THERAPEUTICS INC. entered into Underwriting Agreement with Stifel, Nicolaus & Company, Incorporated valued at $70.2 million (effective 2024-05-03).

“On May 3, 2024, Abeona Therapeutics Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Stifel, Nicolaus & Company, Incorporated (the “Underwriter”) relating to the issuance and sale of an aggregate of (a) 12,285,056 shares of the Company’s common stock (the “Shares”), and (b) pre-funded warrants to purchase 6,142,656 shares of the Company’s common stock (the “Pre-Funded Warrants”) in an underwritten offering (the “Offering”).”

Loar Holdings Inc. entered into Registration Rights Agreement with affiliates of Abrams Capital Management, L.P., GPV Loar LLC and its affiliate Paul S. Levy, affiliates of Blackstone Alternative Credit Advisors L.P., Dirkson Charles and his affiliate and Brett Milgrim and his affiliate, as well as Glenn D’Alessandro and Michael Manella and his affiliate (effective 2024-04-29).

“On April 29, 2024, Loar Holdings Inc. (the “Company,” “we,” “us,” or “our”) entered into a registration rights agreement (the “Registration Rights Agreement”) with affiliates of Abrams Capital Management, L.P. (“Abrams Capital”), GPV Loar LLC and its affiliate Paul S. Levy, affiliates of Blackstone Alternative Credit Advisors L.P., Dirkson Charles and his affiliate and Brett Milgrim and his affiliate (together, the “Demand Stockholders”), as well as Glenn D’Alessandro and Michael Manella and his affiliate (together with the Demand Stockholders, the “Piggyback Stockholders”).”

BLUM HOLDINGS, INC. amended Amended LOI with Safe Accessible Solutions, Inc. valued at $1,671,451 (effective 2024-05-01).

“On May 1, 2024, the Company executed an amended and restated binding letter of intent (the “Amended LOI”) with Safe Accessible Solutions, Inc. (the "Target"), which amended and restated the Operators Only LOI in its entirety.”

RenX Enterprises Corp. entered into Securities Purchase Agreement with Peak One Opportunity Fund, L.P. valued at $1,200,000 (effective 2024-04-29).

“On April 29, 2024, Safe and Green Development Corporation (the “Company”) entered into a Securities Purchase Agreement, dated April 29, 2024 (the “Purchase Agreement”) with Peak One Opportunity Fund, L.P. (“Peak One”), pursuant to which the Company agreed to issue, in a private placement offering (the “Offering”) upon the satisfaction of certain conditions specified in the Purchase Agreement, three Debentures to Peak One in the aggregate principal amount of $1,200,000.”

Sharplink, Inc. entered into ATM Sales Agreement with A.G.P./Alliance Global Partners valued at up to $1,676,366 (effective 2024-05-01).

“On May 1, 2024, SharpLink Gaming, Inc. (“SharpLink” or the “Company”) entered into an ATM Sales Agreement (the “ATM Sales Agreement”) with A.G.P./Alliance Global Partners (the “Agent”) pursuant to which the Company may offer and sell, from time to time, through the Agent, as sales agent and/or principal, shares of its common stock, par value $0.0001 per share (the “Common Stock”), having an aggregate offering price of up to $1,676,366 (“Shares”), subject to certain limitations on the amount of Common Stock that may be offered and sold by the Company set forth in the ATM Sales Agreement (the “Offering”).”

ClimateRock entered into Note with U.N. SDG Support LLC valued at up to $600,000 (effective 2024-04-30).

“On April 30, 2024, ClimateRock (the “ Company ” or “ we ”) issued a promissory note (the “ Note ”) in the aggregate principal amount of up to $600,000 (the “ Extension Funds ”) to U.N. SDG Support LLC, a Delaware limited liability company, the Company’s sponsor (the “ Sponsor ”), pursuant to which the Extension Funds will be deposited into the Company’s trust account”

Quadro Acquisition One Corp. terminated Business Combination Agreement with NHC Holdings II, Inc., NHC Merger Sub, Inc., Global Growth Holdings, LLC, and Greg Lindberg (effective 2024-05-01).

“On May 1, 2024, the Company provided notice to the Seller that it has terminated the BCA pursuant to Section 7.1(e) thereof”

NexPoint Real Estate Finance, Inc. entered into NexBank Loan with NexBank valued at $10.0 million (effective 2024-04-29).

“On April 29, 2024, NexPoint Real Estate Finance Operating Partnership, L.P. (“Borrower”), a subsidiary of NexPoint Real Estate Finance, Inc. (“NREF”) entered into a loan agreement with NexBank, as lender, providing for a loan in the aggregate principal amount of $10.0 million (the “NexBank Loan”).”

Aditxt, Inc. terminated Agreement and Plan of Merger with Evofem Biosciences, Inc..

“the Company received notice from Evofem (the “ Termination Notice ”) that Evofem was exercising its right to terminate the Merger Agreement as a result of the Company’s failure to provide the Initial Parent Equity Investment (as defined in the Merger Agreement, as amended)”

Aditxt, Inc. entered into Agreement and Plan of Merger with Evofem Biosciences, Inc..

“the Company entered into an Agreement and Plan of Merger (the “ Merger Agreement ”) with Adifem, Inc. f/k/a Adicure, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“ Adifem ”) and Evofem Biosciences, Inc., a Delaware corporation (“ Evofem ”)”

Aditxt, Inc. amended Reinstatement and Fourth Amendment to the Merger Agreement with Evofem Biosciences, Inc. valued at $1,000,000 (effective 2024-05-02).

“On May 2, 2024, the Company, Adifem, Inc. f/k/a Adicure, Inc. and Evofem Biosciences, Inc. (“Evofem”) entered into the Reinstatement and Fourth Amendment to the Merger Agreement (the “ Fourth Amendment ”)”